InvestorsHub Logo
Post# of 252301
Next 10
Followers 44
Posts 4583
Boards Moderated 0
Alias Born 07/19/2006

Re: DewDiligence post# 242899

Wednesday, 06/22/2022 11:03:18 PM

Wednesday, June 22, 2022 11:03:18 PM

Post# of 252301
BMY was as excited about interferon lambda for HBV as they were for HCV back in the day. That too was designed as more liver specific with fewer extrahepatic effects (and side effects). It never panned out obviously

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.